There are 487 resources available
LBA3 - Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study
Presenter: Josep Llovet
Session: Presidential Symposium I: Practice-changing trials
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA3
Presenter: Angela Lamarca
Session: Presidential Symposium I: Practice-changing trials
Resources:
Slides
Webcast
Presentation by Expert
Presenter: Stephen Chan
Session: Targeted therapies in biliary tract cancer: Emerging targets and strategies
Resources:
Slides
Webcast
1O - The somatic mutation landscape of the normal and malignant pancreas
Presenter: Pantelis Nicola
Session: Proffered paper session 1: Basic science & Translational research
Resources:
Abstract
Webcast
515MO - Encorafenib + cetuximab (EC) + FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
Presenter: Josep Tabernero
Session: Mini oral session: GI tumours, lower
Resources:
Abstract
Slides
Webcast
516MO - Zanidatamab (Zani) + chemotherapy (CT) in first-line (1L) human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic colorectal cancer (mCRC)
Presenter: Sun Young Rha
Session: Mini oral session: GI tumours, lower
Resources:
Abstract
Slides
Webcast
614MO - Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification
Presenter: Maria Vieito
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
518MO - Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST)
Presenter: Kentaro Yamazaki
Session: Mini oral session: GI tumours, lower
Resources:
Abstract
Slides
Webcast
Invited Discussant 1O and LBA9
Presenter: Ana Vivancos
Session: Proffered paper session 1: Basic science & Translational research
Resources:
Webcast
New developments in the treatment of GIST
Presenter: Cesar Serrano
Session: New developments in the treatment of sarcomas in 2024
Resources:
Slides
Webcast